Form 4: Invivyd, Inc. Insider Granted Stock Options

Invivyd, Inc. reports the grant of 50,000 stock options to Marc Elia, a director and other significant stakeholder, with a potential vesting date in May 2027.

Summary

• Marc Elia, identified as a director and other stakeholder of Invivyd, Inc., was granted 50,000 stock options on May 19, 2026.
• These options have an exercise price of $1.04 and are set to expire on May 18, 2036.
• The options vest in full on the earlier of May 19, 2027, or the date of the Issuer's 2027 Annual Meeting of Stockholders, contingent on Elia's continuous service.
• M28 Capital Management LP, which Elia indirectly controls, is also listed as a reporting person, with Elia's directorship potentially making M28 Capital Management a director by deputization.
• Both Elia and M28 Capital Management disclaim beneficial ownership beyond their pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports a standard insider stock option grant without providing new financial or strategic information about the company's performance or outlook.

Positives

• Grant of stock options to a key insider (director) can align management's interests with shareholders.
• The exercise price of $1.04 suggests the options are granted at a price potentially above the current market price, indicating a belief in future stock appreciation.
• The vesting schedule tied to continuous service and a specific future event (2027 Annual Meeting) incentivizes long-term commitment.

Negatives

• The filing does not provide details on the company's financial performance or strategic updates, making it difficult to assess the broader context of this option grant.
• The disclaimer of beneficial ownership by M28 Capital Management, while standard, can sometimes obscure the true extent of control or interest.

Risks

• The vesting of options is contingent on continuous service, meaning any departure before the vesting date would result in forfeiture.
• The value of the options is directly tied to the future stock performance of Invivyd, Inc., which carries inherent market risks.
• Potential conflicts of interest could arise if M28 Capital Management's actions as an investor are influenced by the directorship held by Marc Elia.

Future Outlook

The future outlook for the granted stock options depends on the continuous service of Marc Elia and the future stock performance of Invivyd, Inc. The options are exercisable until May 18, 2036, with full vesting expected by May 19, 2027, or the 2027 Annual Meeting.

Management Comments

• Marc Elia is deemed to hold the grant for the benefit of M28 Capital Management LP and the funds managed by M28 Capital Management.
• M28 Capital Management may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that Mr. Elia, who indirectly controls M28 Capital Management, currently serves on the board of directors of the Issuer.
• The Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.

Industry Context

StockSavvy.ai notes that the grant of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, aiming to retain key talent and align their financial interests with the company's long-term success, especially during periods of development and potential growth.

Related Party Transactions

• The grant of stock options to Marc Elia, a director, represents a transaction between the company and a related party.

Stakeholder Impact

• Shareholders: The option grant aligns insider interests with potential future stock price appreciation, but also represents potential dilution if exercised. The exercise price suggests management believes the stock will increase in value.
• Employees: Standard practice of equity compensation can motivate other employees, though this specific grant is to a director.
• Management: Provides incentive for continued service and performance.

Next Steps

• Marc Elia must maintain continuous service with Invivyd, Inc. through the vesting date (May 19, 2027, or the 2027 Annual Meeting) to fully vest in the granted stock options.
• The company may continue to issue equity-based compensation to retain and incentivize key personnel.

Key Dates

Keywords

Invivyd, Inc., IVVD, Form 4, Stock Options, Insider Trading, Securities, Director, Beneficial Ownership, Grant, Vesting, M28 Capital Management